# eGVHD vs CARTOX

The clearest difference is ratings volume: CARTOX at 6 against eGVHD's 2. eGVHD's advantage is iOS requirement (9.0 vs 26.4). On price, rating, update cadence and ads there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

On the App Store both sit at effectively the same score — 5.0 for eGVHD against 5.0 for CARTOX. Both are backed by a comparable volume of ratings — 2 and 6 respectively.

eGVHD ships an update every 16 months, CARTOX every 20 months. The most recent releases landed on September 16, 2026 and October 22, 2026 respectively.

## The numbers

| Metric | eGVHD | CARTOX |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [5.0 (2 ratings)](https://appshunter.io/ios/app/egvhd/id1355873791/reviews) | [5.0 (6 ratings)](https://appshunter.io/ios/app/cartox/id1464005828/reviews) |
| Number of ratings | 2 | **6** |
| Positive reviews | — | 100.0% of reviews |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | **Every 16 months** | Every 20 months |
| Monetization | Free | Free |
| Size | 81 MB | 6 MB |
| Requires iOS | **9.0** | 26.4 |
| Devices | **iPhone, iPad, iPod** | iPhone, iPad |
| Age rating | 17+ | 17+ |
| Developer | [nexuzhealth NV](https://appshunter.io/developer/1311365149) | [MD Anderson Cancer Center](https://appshunter.io/developer/618340093) |

## What reviewers say

### eGVHD

[App page](https://appshunter.io/ios/app/egvhd/id1355873791)

This educational tool assists healthcare professionals in assessing and scoring the severity of graft versus host disease (GVHD) in allogeneic stem cell transplantation recipients. It uses an algorithm-driven approach to apply internationally recognized criteria, providing differential information and automatic summaries to aid diagnosis.

**Highlights:** Algorithm-driven assessment, GVHD severity scoring, Differential information display, Automatic summary generation, Educational tool for clinicians

**Features:** macOS Compatibility

**In-app purchases:** none


### CARTOX

[App page](https://appshunter.io/ios/app/cartox/id1464005828)

This medical app aids clinicians in assessing and managing toxicities associated with cellular therapies, including Cytokine Release Syndrome (CRS) and Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS). It provides grading methods and treatment recommendations for healthcare professionals caring for patients undergoing immune effector cell therapy.

**Highlights:** Toxicity grading, CRS assessment, ICANS assessment, Treatment recommendations, Antimicrobial prophylaxis guidance

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is eGVHD free?

eGVHD is free to download, with no in-app purchases.

### Is CARTOX free?

CARTOX is free to download, with no in-app purchases.

### Which has better reviews, eGVHD or CARTOX?

eGVHD and CARTOX are both rated 5.0 out of 5 on the App Store, from 2 and 6 ratings respectively.

### Do eGVHD or CARTOX have ads?

Neither eGVHD nor CARTOX shows ads.

### Which is updated more often, eGVHD or CARTOX?

eGVHD ships an update every 16 months, and CARTOX every 20 months. Most recently, eGVHD was updated on September 16, 2026 and CARTOX on October 22, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*